The performance difference between the Dow Jones Industrial Average DJIA and the Nasdaq composite COMP points to ...

Apple reportedly is looking to ease its memory crunch with a Chinese company, but the dominance of the big three makers ...

Rocket Lab said Monday that it has entered into a definitive agreement that will see Iridium shareholders receive $27 in cash and a number of Rocket Lab shares for each share held ...

I would like you to explain the “break-even” point for Social Security. For example, if I begin collecting at 62 rather than ...

CVC Capital Partners said it has agreed to buy ingredients business Irca from private-equity company Advent. Amsterdam-listed CVC said it would support the next phase of Irca's growth. Advent had ...

Honeywell has completed the spin-off of its aerospace business, the culmination of a multiyear effort to unwind the once sprawling conglomerate. Honeywell Aerospace begins trading on the Nasdaq market ...

Here are some of the stocks making notable moves in Friday's premarket action: Comcast jumped 25% after announcing it will spin off NBCUniversal and Sky. As part of the move, the media conglomerate ...

The "Magnificent Seven" decline last week sent momentum stocks into their fourth worst day of performance in the past 22 years, according to Citigroup. Citigroup’s measure of momentum stocks fell ...

Matador Resources said its majority-owned midstream joint venture has entered a deal to acquire the operating subsidiaries of Cardinal Midstream Partners for $752 million. The company said Monday that ...

Bridgepoint Group shares rose after the company said it was buying real-estate investment platform Kayne Anderson Real Estate in a deal that boosts its assets under management to $117 billion. Shares ...

Infosys Ltd. 500209 shares inched down 0.44% to 1,036.80 Indian rupees Monday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX Index 1 falling 0.48% ...

AbbVie said a key European regulatory committee has recommended expanded approval of its blockbuster autoimmune drug Rinvoq in the autoimmune diseases vitiligo and alopecia areata. AbbVie on Monday ...